Literature DB >> 33282469

Optimal prescription isodose line in SBRT for lung tumor treatment with volumetric-modulated arc therapy.

David Wang1, Albert DeNittis1,2, Tracey Evans1, Thomas Meyer1.   

Abstract

It is crucial to spare lung when treating early stage lung carcinoma with stereotactic body radiotherapy (SBRT) for minimizing the radiation induced toxicities, such as radiation pneumonitis and late fibrosis. A retrospective study was performed with a combination of approaches to determine the optimal range of prescription isodose line (P-IDL) within which lung tissue was best spared in SBRT plans with Volumetric-Modulated Arc Therapy (VMAT) and Monte-Carlo-like dose calculation algorithm. Twenty clinically-delivered SBRT lung plans were optimized using traditional LINAC MLC based approaches: an average P-IDL of (88.8 ± 0.5)% (the error bar of all the data is the 95% confidence interval (CI)). The plans were then re-optimized using a new combination of approaches with variation of P-IDL from 60% to 90% for each case. The combination of approaches included finding and utilizing an optimal P-IDL, implementing tuning ring structures internal and external to the target, as well as normal tissue objective and equivalent. The plans were evaluated with the following indexes: 1. R50%, the ratio of 50% prescription isodose volume to the plan target volume (PTV); 2. V20 and V5, the volume of lung within 20Gy and 5Gy, respectively; 3. PCI, the Paddick comformity index; 4. D2cm, the maximum dose at 2 cm from PTV in any direction; 5. MLD, the mean dose in total lung volume; 6. Focal Index (FI), an indicator of dose in the core of the target. The optimal P-IDL was found to be in the range of 75-80%. The average optimal P-IDL for the 20 cases was (77.9 ± 0.9)%. With the optimization strategies the average PCI was increased by (10.3 ± 2.1)%; the average R50%, V20, V5, D2cm and MLD were decreased by (29.1 ± 4.1)%, (26.9 ± 5.4)%, (13.9 ± 3.5)%, (13.4 ± 4.3)% and (16.7 ± 2.3)%, respectively. The FI was increased by (23.7 ± 1.3)%. The optimal P-IDL range was 75-80% for SBRT VMAT lung treatment plans. The application of the set of optimization approaches can significantly improve the lung sparing in SBRT VMAT plans with AXB dose calculation algorithm and makes treatment plans more conformal in high, intermediate and low dose regions, while higher dose is delivered to the target.
© 2020 Old City Publishing, Inc.

Entities:  

Keywords:  AXB; VMAT; lung SBRT; lung sparing; optimal P-IDL

Year:  2020        PMID: 33282469      PMCID: PMC7717096     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  15 in total

1.  Validation of a new grid-based Boltzmann equation solver for dose calculation in radiotherapy with photon beams.

Authors:  Oleg N Vassiliev; Todd A Wareing; John McGhee; Gregory Failla; Mohammad R Salehpour; Firas Mourtada
Journal:  Phys Med Biol       Date:  2010-01-07       Impact factor: 3.609

2.  A simple dose gradient measurement tool to complement the conformity index.

Authors:  Ian Paddick; Bodo Lippitz
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

3.  Optimization approaches to volumetric modulated arc therapy planning.

Authors:  Jan Unkelbach; Thomas Bortfeld; David Craft; Markus Alber; Mark Bangert; Rasmus Bokrantz; Danny Chen; Ruijiang Li; Lei Xing; Chunhua Men; Simeon Nill; Dávid Papp; Edwin Romeijn; Ehsan Salari
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

4.  Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy.

Authors:  Jun Li; James Galvin; Amy Harrison; Robert Timmerman; Yan Yu; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-24       Impact factor: 7.038

5.  Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac.

Authors:  Chuxiong Ding; Timothy D Solberg; Brian Hrycushko; Lei Xing; John Heinzerling; Robert D Timmerman
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

6.  Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer.

Authors:  Yukinori Matsuo; Keiko Shibuya; Mitsuhiro Nakamura; Masaru Narabayashi; Katsuyuki Sakanaka; Nami Ueki; Ken Miyagi; Yoshiki Norihisa; Takashi Mizowaki; Yasushi Nagata; Masahiro Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-19       Impact factor: 7.038

7.  A technique for stereotactic radiosurgery treatment planning with helical tomotherapy.

Authors:  Emilie T Soisson; Peter W Hoban; Thomas Kammeyer; Jeffrey M Kapatoes; David C Westerly; Amar Basavatia; Wolfgang A Tomé
Journal:  Med Dosim       Date:  2011       Impact factor: 1.482

8.  Comparison of outcomes of stereotactic body radiation therapy delivered with three different technologies to the lung.

Authors:  Sameera S Kumar; Logan Hall; Xingzhe Li; Laura Downes; Andrew Shearer; Brent J Shelton; Samuel Gerring; Ronald C McGarry
Journal:  J Radiosurg SBRT       Date:  2018

9.  Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation.

Authors:  Mark Chan; Matthew Wong; Ronnie Leung; Steven Cheung; Oliver Blanck
Journal:  Radiat Oncol       Date:  2018-02-09       Impact factor: 3.481

10.  Strategies to optimize stereotactic radiosurgery plans for brain tumors with volumetric-modulated arc therapy.

Authors:  David Wang; Albert DeNittis; Yibing Hu
Journal:  J Appl Clin Med Phys       Date:  2020-02-11       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.